Select Pharmaceuticals Portfolio

Fund Profile

Fund profile

Tickers

FPHAX

Fund manager

Fidelity Select Technology Portfolio

Total assets

$1.93 bn

Liabilities

$18.20 mm

Net assets

$1.91 bn

Number of holdings

73.00

73 Holdings

As of Aug 2024

Security	$Holding	Balance	% of Fund	Category	Position	Country
LLY Eli Lilly and Company	458.28 mm	477.36 k shares	23.96	Common equity	Long	USA
NVO Novo Nordisk A/S	255.14 mm	1.83 mm shares	13.34	Common equity	Long	Denmark
ASTRAZENECA PLC SPONS ADR	168.20 mm	1.92 mm shares	8.80	Common equity	Long	UK
BMY Bristol-Myers Squibb Company	94.80 mm	1.90 mm shares	4.96	Common equity	Long	USA
UCB SA	90.84 mm	502.00 k shares	4.75	Common equity	Long	Belgium
GSK GSK plc	85.84 mm	1.95 mm shares	4.49	Common equity	Long	UK
MRK Merck & Co., Inc.	80.68 mm	681.14 k shares	4.22	Common equity	Long	USA
GILD Gilead Sciences, Inc.	61.42 mm	777.50 k shares	3.21	Common equity	Long	USA
Fidelity Cash Central Fund	57.82 mm	57.81 mm shares	3.02	Short-term investment vehicle	Long	USA
LEGN Legend Biotech Corporation	48.01 mm	834.20 k shares	2.51	Common equity	Long	Cayman Islands
DYN Dyne Therapeutics, Inc.	42.67 mm	925.80 k shares	2.23	Common equity	Long	USA
RNA Avidity Biosciences, Inc.	36.08 mm	820.10 k shares	1.89	Common equity	Long	USA
ROYALTY PHARMA PLC	34.60 mm	1.19 mm shares	1.81	Common equity	Long	UK
MRNA Moderna, Inc.	34.34 mm	443.70 k shares	1.80	Common equity	Long	USA
ZTS Zoetis Inc.	31.58 mm	172.10 k shares	1.65	Common equity	Long	USA
MERCK KGAA	28.44 mm	146.30 k shares	1.49	Common equity	Long	Germany
ELAN Elanco Animal Health Incorporated	24.46 mm	1.58 mm shares	1.28	Common equity	Long	USA
SRPT Sarepta Therapeutics, Inc.	23.97 mm	176.50 k shares	1.25	Common equity	Long	USA
BPMC Blueprint Medicines Corporation	21.92 mm	229.40 k shares	1.15	Common equity	Long	USA
GERRESHEIMER AG	19.55 mm	170.90 k shares	1.02	Common equity	Long	Germany
Fidelity Securities Lending Cash Central Fund	16.98 mm	16.97 mm shares	0.89	Short-term investment vehicle	Long	USA
BIIB Biogen Inc.	15.79 mm	77.10 k shares	0.83	Common equity	Long	USA
CTLT Catalent, Inc.	13.95 mm	228.90 k shares	0.73	Common equity	Long	USA
BNTX BioNTech SE	12.75 mm	144.51 k shares	0.67	Common equity	Long	Germany
FINANCIERE DE TUBIZE SA	9.42 mm	70.40 k shares	0.49	Common equity	Long	Belgium
PTCT PTC Therapeutics, Inc.	9.21 mm	260.90 k shares	0.48	Common equity	Long	USA
XENE Xenon Pharmaceuticals Inc.	9.12 mm	226.00 k shares	0.48	Common equity	Long	Canada
GALDERMA GROUP AG	8.93 mm	92.24 k shares	0.47	Common equity	Long	Switzerland
RCUS Arcus Biosciences, Inc.	8.91 mm	520.30 k shares	0.47	Common equity	Long	USA
INSM Insmed Incorporated	7.74 mm	101.20 k shares	0.40	Common equity	Long	USA
EWTX Edgewise Therapeutics, Inc.	6.50 mm	346.90 k shares	0.34	Common equity	Long	USA
LUNG Pulmonx Corporation	6.32 mm	864.00 k shares	0.33	Common equity	Long	USA
ION BEAM APPLICATIONS SA REG	6.16 mm	463.76 k shares	0.32	Common equity	Long	Belgium
FULC Fulcrum Therapeutics, Inc.	5.84 mm	683.60 k shares	0.31	Common equity	Long	USA
MERUS B.V.	5.51 mm	108.00 k shares	0.29	Common equity	Long	Netherlands
NEWAMSTERDAM PHARMA COMPANY NV	5.42 mm	330.20 k shares	0.28	Common equity	Long	Netherlands
AXSM Axsome Therapeutics, Inc.	5.19 mm	58.40 k shares	0.27	Common equity	Long	USA
ASND Ascendis Pharma A/S	5.00 mm	36.10 k shares	0.26	Common equity	Long	Denmark
GLUE Monte Rosa Therapeutics, Inc.	4.91 mm	796.40 k shares	0.26	Common equity	Long	USA
BEAM Beam Therapeutics Inc.	4.74 mm	177.80 k shares	0.25	Common equity	Long	USA
HRMY Harmony Biosciences Holdings, Inc.	4.70 mm	130.68 k shares	0.25	Common equity	Long	USA
AGL agilon health, inc.	4.66 mm	1.14 mm shares	0.24	Common equity	Long	USA
SYRE Spyre Therapeutics, Inc.	4.28 mm	148.74 k shares	0.22	Common equity	Long	USA
AVBP ArriVent BioPharma, Inc. Common Stock	4.05 mm	151.60 k shares	0.21	Common equity	Long	USA
NTLA Intellia Therapeutics, Inc.	3.88 mm	172.90 k shares	0.20	Common equity	Long	USA
ALNY Alnylam Pharmaceuticals, Inc.	3.85 mm	14.67 k shares	0.20	Common equity	Long	USA
OCUL Ocular Therapeutix, Inc.	3.77 mm	427.50 k shares	0.20	Common equity	Long	USA
ACLX Arcellx, Inc.	2.83 mm	41.10 k shares	0.15	Common equity	Long	USA
CRISPR THERAPEUTICS AG	2.53 mm	53.00 k shares	0.13	Common equity	Long	Switzerland
NYXOAH SA	2.41 mm	298.20 k shares	0.13	Common equity	Long	Belgium
GPCR Structure Therapeutics Inc.	2.06 mm	54.00 k shares	0.11	Common equity	Long	Cayman Islands
AGOMAB THERAPEUTICS SA SER C PC PP	2.04 mm	7.73 k shares	0.11	Preferred equity	Long	Belgium
PARAGON BIOSCIENCES EMALEX CAPITAL INC SER C PC PP	1.98 mm	158.88 k shares	0.10	Preferred equity	Long	USA
GBIO Generation Bio Co.	1.89 mm	715.28 k shares	0.10	Common equity	Long	USA
PROTHENA CORP PLC	1.69 mm	75.80 k shares	0.09	Common equity	Long	Ireland
ANNX Annexon, Inc.	1.66 mm	291.89 k shares	0.09	Common equity	Long	USA
CASTLE CREEK BIOSCIENCES INC SER D-1 PC PP	1.45 mm	6.31 k shares	0.08	Preferred equity	Long	USA
CYTK Cytokinetics, Incorporated	1.32 mm	23.10 k shares	0.07	Common equity	Long	USA
NYXOAH SA	1.26 mm	157.31 k shares	0.07	Common equity	Long	Belgium
BLUE bluebird bio, Inc.	1.25 mm	2.23 mm shares	0.07	Common equity	Long	USA
GALAPAGOS GENOMICS NV SPON AR	1.07 mm	36.90 k shares	0.06	Common equity	Long	Belgium
EVOZYNE INC CPIK 6% 09/13/2028 P/P	1.03 mm	921.29 k principal	0.05	Debt	Long	USA
EVOZYNE INC SER B PC PP	1.02 mm	56.64 k shares	0.05	Preferred equity	Long	USA
ARVN Arvinas, Inc.	688.01 k	26.30 k shares	0.04	Common equity	Long	USA
PARAGON BIOSCIENCES EMALEX CAPITAL INC SER D-2 PC PP	267.93 k	22.48 k shares	0.01	Preferred equity	Long	USA
SDZNY Sandoz Group AG	219.18 k	4.98 k shares	0.01	Common equity	Long	Switzerland
PARAGON BIOSCIENCES EMALEX CAPITAL INC SER D-1 PC PP	180.29 k	14.40 k shares	0.01	Preferred equity	Long	USA
EVOZYNE INC SER A PC PP	106.73 k	5.90 k shares	0.01	Preferred equity	Long	USA
CASTLE CREEK BIOSCIENCES INC SER C PC PERP PP	51.21 k	200.00 shares	0.00	Preferred equity	Long	USA
CASTLE CREEK BIOSCIENCES INC SER D-2 PC PP	17.45 k	85.00 shares	0.00	Preferred equity	Long	USA
LEAP THERAPEUTICS INC WT	71.51	60.60 k shares	0.00	Common equity	Long	USA
MEDAVAIL HOLDINGS INC PIPE	0.01	66.00 shares	0.00	Common equity	Long	USA
AGOMAB THERAPEUTICS SA ANTI-DILUTION WT PP 10/10/2033	0	10.00 shares	0.00	Common equity	Long	Belgium